| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,143 |
12,347 |
$1.18M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,918 |
12,415 |
$799K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,407 |
4,033 |
$316K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,237 |
3,495 |
$262K |
| 99215 |
Prolong outpt/office vis |
2,000 |
1,609 |
$213K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,062 |
1,872 |
$144K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,749 |
4,746 |
$134K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,301 |
7,984 |
$117K |
| 90677 |
|
881 |
648 |
$99K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,877 |
2,449 |
$76K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,881 |
4,512 |
$47K |
| 90723 |
|
2,456 |
2,114 |
$43K |
| 90670 |
|
2,378 |
2,192 |
$38K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
467 |
406 |
$34K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,147 |
922 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
306 |
261 |
$30K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,703 |
6,843 |
$29K |
| 90680 |
|
1,529 |
1,311 |
$28K |
| 96160 |
|
13,442 |
11,481 |
$27K |
| 99381 |
|
476 |
354 |
$26K |
| 99188 |
|
1,301 |
1,201 |
$25K |
| 90648 |
|
2,387 |
2,105 |
$23K |
| 87807 |
|
1,831 |
1,548 |
$21K |
| 90633 |
|
1,647 |
1,487 |
$20K |
| 85018 |
|
7,636 |
6,831 |
$16K |
| 90710 |
|
384 |
334 |
$16K |
| 94760 |
|
14,054 |
11,134 |
$15K |
| 83655 |
|
1,254 |
1,110 |
$13K |
| 96127 |
|
2,928 |
2,172 |
$13K |
| 90651 |
|
196 |
173 |
$13K |
| 92551 |
|
1,367 |
1,213 |
$12K |
| 90461 |
|
5,629 |
4,490 |
$10K |
| 90686 |
|
820 |
764 |
$10K |
| 99177 |
|
2,483 |
2,270 |
$10K |
| 81002 |
|
3,665 |
3,207 |
$9K |
| 90716 |
|
369 |
323 |
$9K |
| 90681 |
|
499 |
412 |
$8K |
| 90734 |
|
193 |
164 |
$8K |
| 99173 |
|
3,342 |
3,005 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
673 |
564 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
562 |
419 |
$6K |
| 90707 |
|
352 |
307 |
$6K |
| 90696 |
|
332 |
286 |
$5K |
| 96161 |
|
2,722 |
1,967 |
$5K |
| 87634 |
|
96 |
78 |
$4K |
| 90700 |
|
342 |
320 |
$4K |
| 90647 |
|
392 |
332 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
285 |
129 |
$2K |
| 69210 |
|
52 |
46 |
$2K |
| 94664 |
|
205 |
182 |
$2K |
| 80061 |
Lipid panel |
186 |
136 |
$2K |
| 90685 |
|
163 |
146 |
$2K |
| 81003 |
|
618 |
543 |
$1K |
| 36416 |
|
8,224 |
6,894 |
$1K |
| 99000 |
|
1,476 |
1,198 |
$878.28 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
13 |
$803.95 |
| 99401 |
|
39 |
38 |
$759.30 |
| 90661 |
|
114 |
85 |
$702.95 |
| 90715 |
|
43 |
42 |
$669.10 |
| 0071A |
|
16 |
16 |
$666.00 |
| 0072A |
|
14 |
14 |
$584.00 |
| A7015 |
Aerosol mask, used with dme nebulizer |
383 |
327 |
$311.23 |
| 99072 |
|
3,286 |
2,826 |
$196.32 |
| 69209 |
|
34 |
18 |
$170.48 |
| 99050 |
|
14 |
14 |
$114.34 |
| 99051 |
|
593 |
413 |
$50.09 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
413 |
357 |
$44.95 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
30 |
16 |
$32.49 |
| A9150 |
Non-prescription drugs |
621 |
528 |
$25.70 |
| 94761 |
|
13 |
12 |
$14.48 |
| 91307 |
|
80 |
78 |
$0.00 |